Skip to the page

Data / Form D filings / Kastle Biopartners II LP

Kastle Biopartners II LP: Form D filing

Kastle Biopartners II LP, a company in Boca Raton, FL, filed a Form D with the SEC in 2025. The latest, on June 27, 2025, reports $14.4 million sold of a $100 million offering to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1100 HOLLAND DR., Boca Raton, FL, 33487
Phone
(332) 233-7541
Industry
Other
Entity type
Limited Partnership
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2073274

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 27, 2025New notice$100,000,000$14,400,000$85,600,0006Mar 14, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Josh SharanDirector
- Camelot BioVentures II LLCExecutive Officer, Director
Peter KashExecutive Officer, Director
Colby KashExecutive Officer, Director

Other companies in Florida that filed recently

Every Form D from the week of Jun 23, 2025 · All recent filings in Florida · All recent Other filings

Read from SEC EDGAR. Amount sold is what Kastle Biopartners II LP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.